Differentiation of primary affective illness from situational, symptomatic, and secondary depressions
- PMID: 444017
- DOI: 10.1001/archpsyc.1979.01780060025002
Differentiation of primary affective illness from situational, symptomatic, and secondary depressions
Abstract
Analysis of family history and antidepressant drug response variables of 100 "neurotic" depressives followed up prospectively over three to four years disclosed that primary depressions (unipolar and bipolar) could be distinguished from nonprimary cases by (1) the early occurrence of "pharmacological-hypomania;" (2) family history of bipolar illness; (3) family history for affective disorder in two or three consecutive generations, especially when "loaded." Although each of these variables alone occurred in only one fifth to one third of the primary group, they individually displayed better than 95% specificity for it. Thus, the confidence with which the diagnosis of primary affective illness could be made in the presence of any of these variables ranged from 88% to 100%. These findings argue for considering such nonsymptomatological variables for their potential in strengthening the phenomenologic diagnostic criteria for depressive illness.
Similar articles
-
Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors.J Affect Disord. 1983 May;5(2):115-28. doi: 10.1016/0165-0327(83)90004-6. J Affect Disord. 1983. PMID: 6222091
-
Bipolar illness in adolescents with major depression: clinical, genetic, and psychopharmacologic predictors in a three- to four-year prospective follow-up investigation.Arch Gen Psychiatry. 1982 May;39(5):549-55. doi: 10.1001/archpsyc.1982.04290050029007. Arch Gen Psychiatry. 1982. PMID: 7092488
-
Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group.Am J Psychiatry. 1977 Nov;134(11):1227-33. doi: 10.1176/ajp.134.11.1227. Am J Psychiatry. 1977. PMID: 910973
-
ECNP consensus meeting. Bipolar depression. Nice, March 2007.Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Eur Neuropsychopharmacol. 2008. PMID: 18501566 Review.
-
[Depressive states in children and adolescents].Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1979 Jul-Sep;24(3):195-201. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1979. PMID: 394254 Review. Romanian. No abstract available.
Cited by
-
Psychopathology in the families of inpatient affective disordered adolescents.Child Psychiatry Hum Dev. 1995 Winter;26(2):71-84. doi: 10.1007/BF02353232. Child Psychiatry Hum Dev. 1995. PMID: 8565649
-
Serum miRNA as a possible biomarker in the diagnosis of bipolar II disorder.Sci Rep. 2020 Jan 24;10(1):1131. doi: 10.1038/s41598-020-58195-0. Sci Rep. 2020. PMID: 31980721 Free PMC article.
-
Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder.PLoS One. 2013 Jun 27;8(6):e66847. doi: 10.1371/journal.pone.0066847. Print 2013. PLoS One. 2013. PMID: 23826157 Free PMC article. Clinical Trial.
-
A clinical study of chronic depression.Indian J Psychiatry. 1991 Oct;33(4):261-5. Indian J Psychiatry. 1991. PMID: 21897468 Free PMC article.
-
Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.J Psychiatr Res. 2013 Oct;47(10):1343-8. doi: 10.1016/j.jpsychires.2013.06.017. Epub 2013 Jul 18. J Psychiatr Res. 2013. PMID: 23870798 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources